Search Count: 24
![]() |
Crystal Structure Of I83E Meditope-Enabled Trastuzumab With Azido-Meditope
Organism: Homo sapiens, Finegoldia magna, Staphylococcus aureus, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.88 Å Release Date: 2018-03-14 Classification: IMMUNE SYSTEM Ligands: MRY |
Organism: Homo sapiens, Finegoldia magna, Staphylococcus aureus, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2018-03-14
Ligands: MRY
![]() |
Crystal Structure Of I83E Meditope-Enabled Trastuzumab With Azido-Peg3-Meditope
Organism: Homo sapiens, Finegoldia magna, Staphylococcus aureus, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.74 Å Release Date: 2018-03-14 Classification: IMMUNE SYSTEM Ligands: MRY |
Organism: Homo sapiens, Finegoldia magna, Staphylococcus aureus, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2018-03-14
Ligands: MRY
![]() |
Cetuximab Fab In Complex With L5E Meditope Variant
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.53 Å Release Date: 2016-10-26 Classification: IMMUNE SYSTEM Ligands: PO4 |
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2016-10-26
Ligands: PO4
![]() |
Cetuximab Fab In Complex With F3H Meditope Variant
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2016-10-26 Classification: IMMUNE SYSTEM Ligands: PO4, NAG, MRY |
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2016-10-26
Ligands: PO4, NAG, MRY
![]() |
Cetuximab Fab In Complex With L5Y Meditope Variant
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.48 Å Release Date: 2016-10-26 Classification: IMMUNE SYSTEM Ligands: PO4, NAG |
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2016-10-26
Ligands: PO4, NAG
![]() |
Cetuximab Fab In Complex With L10Q Meditope Variant
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2016-10-26 Classification: IMMUNE SYSTEM Ligands: PO4, NAG |
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2016-10-26
Ligands: PO4, NAG
![]() |
Structure Of Cetuximab Fab With Cyclic F3Q Variant Of The Meditope
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.55 Å Release Date: 2016-10-26 Classification: IMMUNE SYSTEM Ligands: PO4 |
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2016-10-26
Ligands: PO4
![]() |
Cetuximab Fab In Complex With 4-Bromophenylalanine Meditope Variant
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.50 Å Release Date: 2016-10-26 Classification: IMMUNE SYSTEM Ligands: PO4 |
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2016-10-26
Ligands: PO4
![]() |
Cetuximab Fab In Complex With 3-Bromophenylalanine Meditope Variant
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.48 Å Release Date: 2016-10-26 Classification: IMMUNE SYSTEM Ligands: PO4, NAG |
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2016-10-26
Ligands: PO4, NAG
![]() |
Cetuximab Fab In Complex With 2-Bromophenylalanine Meditope Variant
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.51 Å Release Date: 2016-10-26 Classification: IMMUNE SYSTEM Ligands: PO4 |
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2016-10-26
Ligands: PO4
![]() |
Cetuximab Fab In Complex With Arg9Cir Meditope Variant
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.48 Å Release Date: 2016-10-26 Classification: IMMUNE SYSTEM Ligands: PO4 |
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2016-10-26
Ligands: PO4
![]() |
Cetuximab Fab In Complex With Arg8Cir Meditope Variant
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.48 Å Release Date: 2016-10-26 Classification: IMMUNE SYSTEM Ligands: PO4 |
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2016-10-26
Ligands: PO4
![]() |
Cetuximab Fab In Complex With Cqfda(Ph)2Strrlkc
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.48 Å Release Date: 2016-10-26 Classification: IMMUNE SYSTEM Ligands: PO4, MRY |
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2016-10-26
Ligands: PO4, MRY
![]() |
Cetuximab Fab In Complex With Cqa(Ph)2Dlstrrlkc Peptide
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.48 Å Release Date: 2016-10-26 Classification: IMMUNE SYSTEM Ligands: PO4, NAG |
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2016-10-26
Ligands: PO4, NAG
![]() |
Cetuximab Fab In Complex With Cqydlstrrlkc
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.53 Å Release Date: 2016-10-26 Classification: IMMUNE SYSTEM Ligands: PO4, NAG |
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2016-10-26
Ligands: PO4, NAG
![]() |
Cetuximab Fab In Complex With L5Q Meditope Variant
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.84 Å Release Date: 2016-10-26 Classification: IMMUNE SYSTEM Ligands: PO4 |
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2016-10-26
Ligands: PO4
![]() |
Cetuximab Fab In Complex With Cyclic Beta-Alanine-Linked Meditope
Organism: Mus musculus, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.55 Å Release Date: 2016-06-15 Classification: IMMUNE SYSTEM Ligands: PO4 |
Organism: Mus musculus, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2016-06-15
Ligands: PO4
![]() |
Cetuximab Fab In Complex With Cyclic Linked Meditope
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.67 Å Release Date: 2016-06-15 Classification: IMMUNE SYSTEM Ligands: NAG, CY3 |
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2016-06-15
Ligands: NAG, CY3
![]() |
Cetuximab Fab In Complex With Amidated Meditope
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.48 Å Release Date: 2016-06-15 Classification: IMMUNE SYSTEM Ligands: PO4 |
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2016-06-15
Ligands: PO4
![]() |
Cetuximab Fab In Complex With Cqfdlstrrlrcggsk Meditope
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.60 Å Release Date: 2016-06-15 Classification: IMMUNE SYSTEM Ligands: NAG, PO4 |
Organism: Mus musculus, homo sapiens, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2016-06-15
Ligands: NAG, PO4
